Infectious Diseases News and Research

RSS

CDC, ZKBS classifies Advaxis Agents as non-pathogenic materials

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has received affirmation by the Public Health Service of the U. S. Centers for Disease Control and Prevention and the Zentrale Kommission für die Biologische Sicherheit, the Central Commission for Biological Safety in Germany, that Advaxis strains, constructs and immunotherapies have been attenuated to the point that they are classified as non-pathogenic materials for handling and shipment.

30 Jul 2011

Hospitals miss opportunities to diagnose patients infected with HIV in EDs: UC research

New University of Cincinnati research on HIV testing at local emergency departments shows that hospitals miss opportunities to diagnose patients who do not know they are infected with HIV, even when a regular testing program is in place.

30 Jul 2011

UH Case Medical Center to commence Phase 1 clinical trial on TMC207

University Hospitals Case Medical Center will begin a Phase 1 clinical trial on a new experimental anti-tuberculosis drug called TMC207.

30 Jul 2011

ELPA, WHA announce educational program for hepatitis B patients

The European Liver Patients Association (ELPA) and the World Hepatitis Alliance (WHA), announced today on the 4th annual World Hepatitis Day that 'PATH B - "Patients and Professionals Acting Together for Hepatitis B" - My journey with chronic hepatitis B', a comprehensive educational resource designed to improve the lives of people living with chronic hepatitis B, is to be launched in August 2011.

29 Jul 2011

MSNBC's Chris Matthews interviews NIAID head Anthony Fauci

The Center for Global Health Policy's "Science Speaks" blog features video of an interview of Anthony Fauci, director of the NIH National Institute of Allergy and Infectious Diseases, that was conducted by MSNBC "Hardball" host Chris Matthews at a Capitol Hill briefing on Tuesday, which was hosted by the Foundation for AIDS Research.

29 Jul 2011

Sorrento receives NIAID Phase I STTR grant to develop vaccines against C. difficile infection

Sorrento Therapeutics, Inc. announced today that it has received a Phase I Small Business Technology Transfer Research grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.

29 Jul 2011

ELPA, WHA to launch PATH B programme for patients with chronic hepatitis B

28 Jul 2011

Safeguard Scientifics reports consolidated net income of $121.8M for second quarter 2011

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced results of operations for the second quarter of 2011.

27 Jul 2011

UBC research projects receive CIHR grants to promote greater equity in global health

Three research projects at the University of British Columbia have won five-year grants totaling nearly $6 million from the Canadian Institutes of Health Research (CIHR) to promote greater equity in global health.

27 Jul 2011

Kadmon, Dyax enter license agreement for antibody phage display libraries

Dyax Corp. and Kadmon Corporation, LLC announced today that Dyax has granted Kadmon a non-exclusive license to Dyax's proprietary "gold-standard" antibody phage display libraries for the discovery and development of therapeutic antibodies.

26 Jul 2011

Physician-targeted education campaign reduces outpatient antibiotic use in Quebec

Antibiotic overuse and resistance have emerged as major threats during the past two decades. Following an outbreak of Clostridium difficile infections, which often result from antibiotic use, health care professionals in Quebec, Canada targeted physicians and pharmacists with an education campaign that reduced outpatient antibiotic use, according to a study published in Clinical Infectious Diseases and now available online.

26 Jul 2011

CNBG, Aeras sign MOU to develop TB vaccines in China and around the world

Aeras and the China National Biotech Group (CNBG) today announced the signing of a memorandum of understanding for the organizations to pursue opportunities to jointly develop tuberculosis (TB) vaccines in China and potentially other parts of the world.

26 Jul 2011

Advaxis submits protocol revision for ADXS-HPV CIN Phase II study

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has submitted a protocol revision that has passed FDA review for the enrollment of the next 40 subject "mid strength" dose cohort in the dose-ranging Phase II study of ADXS-HPV, an immunotherapy for Cervical Intraepithelial Neoplasia.

26 Jul 2011

Women & Infants creates fully integrated center for high-risk pregnancy

Every pregnancy deserves special treatment. But when a woman with a normal pregnancy has a complication or a woman with a medical issue becomes pregnant, she needs highly specialized care.

26 Jul 2011

Chicken pox vaccine reduced related deaths by 88%

The team of researchers found that although in 2006 a second dose was added to the vaccination roster, the decrease in deaths occurred largely during the time when just one shot was recommended. While chickenpox-related deaths are now relatively rare, the new two-dose regimen may eliminate them altogether, they said. The double dose will further reduce sick days and medical care associated with chickenpox and its complications, the study authors said.

25 Jul 2011

New WHO policy recommendation warns against use of blood tests for active TB

A new policy recommendation released on 20 July by the World Health Organization (WHO) warns against the use of serological (blood) tests to diagnose active tuberculosis.

25 Jul 2011

Researchers dissociate beneficial and detrimental impacts of maternal regulatory T cells

A normal but concerning consequence of pregnancy is the fact that pregnant women are more susceptible to infection. University of Minnesota Medical School researchers have identified the underlying mechanisms for this physiologic immune suppression that may lead to new therapies to help ward off infections during pregnancy.

22 Jul 2011

IAS conference concludes with positive news on HIV prevention

"Scientists on Wednesday wrapped up their biggest forum in the 30-year history of AIDS, unveiling stunning weapons to prevent the spread of HIV," Agence France-Presse reports about the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Rome.

22 Jul 2011

HIV-infected MSM more likely to contract HCV through sex

Sexual transmission of hepatitis C virus (HCV) is considered rare. But a new study by researchers at Mount Sinai School of Medicine, working with the Centers for Disease Control and Prevention (CDC), provides substantial evidence that men with HIV who have sex with other men (MSM) are at increased risk for contracting HCV through sex.

22 Jul 2011

EMA says link between narcolepsy and Pandemrix 2009 H1N1 vaccine exists

A final review result from Europe's drug regulatory agency released a positive link between narcolepsy and the Pandemrix 2009 H1N1 vaccine. The agency recommends a labeling change that limits the vaccine's use in children and teens to when protection is needed and seasonal trivalent vaccine isn't available.

21 Jul 2011